
Sign up to save your podcasts
Or
Send us a text
Iscaffpharma CEO Per Setterberg shares how they are focusing on developing better treatments of aggressive cancers by providing 3D scaffolds mimicking human tumour environment as a platform for research and development.
Upcoming SLAS Events:
SLAS Europe 2025 Conference and Exhibition
View the full events calendar
Send us a text
Iscaffpharma CEO Per Setterberg shares how they are focusing on developing better treatments of aggressive cancers by providing 3D scaffolds mimicking human tumour environment as a platform for research and development.
Upcoming SLAS Events:
SLAS Europe 2025 Conference and Exhibition
View the full events calendar